EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Targeting the NLRP3 by Natural Compounds: Therapeutic Strategies to Mitigate Doxorubicin-Induced Cardiotoxicity

Dareuosh Shackebaei, Kheirollah Yari, Nader Rahimi, Sara Gorgani, Fatemeh Yarmohammadi

Cell Biochemistry and Biophysics · 2025

DOI: 10.1007/s12013-025-01723-4 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cell Biochemistry and Biophysics, 2025. Verfasst von Dareuosh Shackebaei und 4 weiteren Autor:innen. Beteiligte Einrichtung: Medical Biology Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran. Hauptthemen laut MEDLINE: NLR Family, Pyrin Domain-Containing 3 Protein, Doxorubicin, Cardiotoxicity, Cardiotonic Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 97 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Doxorubicin (DOX), a widely utilized anthracycline chemotherapy agent, is known for its potent anticancer efficacy across various malignancies. However, its clinical use is considerably restricted due to the risk of dose-dependent cardiotoxicity, which can lead to long-term heart dysfunction. The underlying mechanism of DOX-induced cardiotoxicity has been associated with the formation of reactive oxygen species (ROS) and disrupting cellular signaling pathways. This is particularly relevant to the activation of the NLRP3 inflammasome, which triggers inflammation and pyroptosis in cardiac cells. In recent years, there has been growing interest in natural compounds that exhibit potential cardioprotective effects against the adverse cardiac effects of DOX. The present study showed that specific natural compounds, such as honokiol, resveratrol, cynaroside, and curcumin, can confer significant protection against DOX-induced cardiotoxicity through the modulation of NLRP3 inflammasome signaling pathways. In summary, incorporating natural compounds into treatment plans could be a practical approach to improve the safety profile of DOX, thereby protecting cardiac health through the regulation of the NLRP3 pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NLR Family, Pyrin Domain-Containing 3 ProteinDoxorubicinCardiotoxicityCardiotonic AgentsBiological ProductsAnimalsResveratrolInflammasomesSignal TransductionReactive Oxygen SpeciesCurcuminLignansBiphenyl CompoundsHumansMaleMiceMyocytes, CardiacAllyl CompoundsPhenols

Stichwörter der Autor:innen

CardiomyopathyChemotherapyHerbal medicineInflammasomePyroptosis

Substanzen

NLR Family, Pyrin Domain-Containing 3 ProteinDoxorubicinResveratrolInflammasomeshonokiolReactive Oxygen SpeciesCurcuminLignansBiphenyl CompoundsCardiotonic Agents

Autor:innen und Institutionen

  • Medical Biology Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran.
  • Department of Physiology, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran.
  • Department of Occupational Health and Safety Engineering, Faculty of Health, Ilam University of Medical Sciences, Ilam, Iran.
  • Neuroscience Research Center, Department of Anatomy, Faculty of Medicine, Golestan University of Medical Sciences, Gorgan, Iran.
  • Medical Biology Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran. Fatemeh.yarmohammadi@kums.ac.ir.

Zitieren

APA

Shackebaei, D., Yari, K., Rahimi, N., Gorgani, S., & Yarmohammadi, F. (2025). Targeting the NLRP3 by Natural Compounds: Therapeutic Strategies to Mitigate Doxorubicin-Induced Cardiotoxicity. Cell Biochemistry and Biophysics. https://doi.org/10.1007/s12013-025-01723-4

Vancouver

Shackebaei D, Yari K, Rahimi N, Gorgani S, Yarmohammadi F. Targeting the NLRP3 by Natural Compounds: Therapeutic Strategies to Mitigate Doxorubicin-Induced Cardiotoxicity. Cell Biochemistry and Biophysics. 2025. doi:10.1007/s12013-025-01723-4

BibTeX
@article{Shackebaei2025,
  author = {Shackebaei, Dareuosh and Yari, Kheirollah and Rahimi, Nader and Gorgani, Sara and Yarmohammadi, Fatemeh},
  title = {Targeting the NLRP3 by Natural Compounds: Therapeutic Strategies to Mitigate Doxorubicin-Induced Cardiotoxicity},
  journal = {Cell Biochemistry and Biophysics},
  year = {2025},
  doi = {10.1007/s12013-025-01723-4}
}
Kostenlos starten →